Cost-Effectiveness of IDegAsp in Diabetes Manag...

By Melike Belenli Gümüş

June 24, 2024

Introduction Type 2 diabetes impacts over 500 million individuals globally, leading to substantial healthcare cost...
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Enhancing Surgical Recovery Predictions with AI: A New Approach
The Economic Benefits of Preventive Health Programs
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Brucellosis Control in Armenia: A Holistic Approach
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from Türkiye
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor